Effects of bromocriptine on catecholamine receptors mediating cardiovascular responses in the pithed rat
- PMID: 2991290
- DOI: 10.1111/j.1474-8673.1985.tb00113.x
Effects of bromocriptine on catecholamine receptors mediating cardiovascular responses in the pithed rat
Abstract
The interaction of bromocriptine with several catecholamine receptors that control the sympathetic responses at cardiac and vascular level has been studied in pithed adrenalectomized and vagotomized normotensive rats. Bromocriptine (30 and 100 micrograms/kg) inhibited the stimulation-induced pressor responses in the pithed rat without modifying the pressor responses induced by noradrenaline. Sulpiride (0.3 mg/kg) abolished the effects of bromocriptine (30 micrograms/kg) but only partially prevented the effects of bromocriptine (100 micrograms/kg) on the stimulation-induced pressor responses. Yohimbine (0.3 mg/kg) partially antagonised the inhibitory effect of bromocriptine on stimulation-induced pressor responses. Combination of yohimbine and sulpiride abolished attenuation of the stimulation-induced pressor responses by bromocriptine (100 micrograms/kg). Bromocriptine (0.3 and 1 mg/kg) shifted to the right the frequency-response curve of increases in heart rate. This effect was prevented by yohimbine (0.3 mg/kg) but not by sulpiride (0.3 mg/kg). The same doses of bromocriptine were ineffective on heart rate increases induced by noradrenaline. Bromocriptine (0.3 and 1 mg/kg) shifted to the right the increases in diastolic blood pressure induced by methoxamine without modifying those induced by xylazine and noradrenaline. These results suggest that bromocriptine acts on the peripheral sympathetic nervous system of the pithed rat as an agonist of presynaptic dopamine receptors and alpha 2-adrenoreceptors and as an antagonist of postsynaptic alpha 1-adrenoreceptors.
Similar articles
-
Effects of ergotamine on cardiovascular catecholamine receptors in the pithed rat.Gen Pharmacol. 1988;19(3):475-81. doi: 10.1016/0306-3623(88)90051-1. Gen Pharmacol. 1988. PMID: 2843416
-
Cardiovascular effects of bromocriptine in rats: role of peripheral adrenergic and dopaminergic receptors.J Auton Pharmacol. 1990 Apr;10(2):85-96. doi: 10.1111/j.1474-8673.1990.tb00008.x. J Auton Pharmacol. 1990. PMID: 2161850
-
Effects of some antipsychotic drugs on cardiovascular catecholamine receptors in the rat.J Auton Pharmacol. 1989 Dec;9(6):397-409. doi: 10.1111/j.1474-8673.1989.tb00480.x. J Auton Pharmacol. 1989. PMID: 2576023
-
Presynaptic inhibition by dihydroergotoxine of the response to peripheral sympathetic nerve stimulation in rats.Eur J Pharmacol. 1987 Jun 26;138(3):433-7. doi: 10.1016/0014-2999(87)90484-5. Eur J Pharmacol. 1987. PMID: 3622619
-
Alpha-adrenoceptors involved on the cardiovascular response induced by mianserin in the pithed rat.Gen Pharmacol. 1992 May;23(3):509-14. doi: 10.1016/0306-3623(92)90120-9. Gen Pharmacol. 1992. PMID: 1324869
Cited by
-
Synergistically acting agonists and antagonists of G protein-coupled receptors prevent photoreceptor cell degeneration.Sci Signal. 2016 Jul 26;9(438):ra74. doi: 10.1126/scisignal.aag0245. Sci Signal. 2016. PMID: 27460988 Free PMC article.
-
Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus.Endocrinol Diabetes Metab. 2019 Nov 13;3(1):e00101. doi: 10.1002/edm2.101. eCollection 2020 Jan. Endocrinol Diabetes Metab. 2019. PMID: 31922028 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources